14.01.2013 Views

Final Programme - iuphar

Final Programme - iuphar

Final Programme - iuphar

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

W19 Influence of degeneration and repair in the CNS<br />

and periphery<br />

Mon 432 Neuroprotective effect of serofendic acid on in vitro and in vivo neuronal injury<br />

Toshiaki Kume, (Japan), Y Izumi, A Akaike<br />

Mon 433 Quercetin protects cortical neurovascular unit against amyloid β25-35 peptide-induced amnesia in mice<br />

Rui Liu, (PR China), GF Qiang, Y Jian, X Lan, HG Yang, GH Du<br />

Mon 434 Efficacy of Panax notoginseng saponins on patients with intracerebral hemorrhage<br />

Yumin Luo, (PR China), Q Liu, J Song, P Liu, L Gao<br />

Mon 435 Dopamine inhibits NO production by LPS-activated microglia through the formation of quinoprotein<br />

Sadaaki Maeda, (Japan), A Tozawa, T Kitamoto, A Yamamuro, A Kasai, Y Yoshioka<br />

Mon 436 The seizures and status epilepticus in emergency department of pediatrics.The clinical and<br />

pharmacological implications of some benzodiazepines<br />

Ioan Magyar, (Romania)<br />

Mon 437 Ventral tegmental area NMDA receptors play a role in the effect of scopolamine on inhibitory avoidance<br />

memory in rats<br />

Gelavizh Mahmoudi, (Iran), M-R Zarrindast, A Pourmotabbed<br />

Mon 438 Distribution of the CYP2C9*2, CYP2C9*3 gene variants in a Romanian epileptic patients group<br />

Florentina Claudia Militaru, (Romania), A Buzoianu, C Bocsan, A Trifa, R Popp, LP Dumbrava,<br />

E Brusturean<br />

Mon 439 Angiotensin II type 1 (AT1) receptor blocker, telmisartan, protects brain damage induced by ischemia<br />

and amyloid-β injection partly due to PPAR-γ activation<br />

Masaki Mogi, (Japan), J Iwanami, K Tsukuda, M Horiuchi<br />

Mon 440 Noradrenaline protects neurons against hydrogen peroxide toxicity by increasing the release of<br />

glutathione from astrocytes<br />

Toshiki Motegi, (Japan), Y Yoshioka, A Yamamuro, A Kasai, S Maeda<br />

Mon 441 Functional analysis of Transferrin receptor-1 expressed in brain<br />

Yukary Nakamura, (Japan), T Takarada, Y Yoneda<br />

Mon 442 Pentacycloundecane conjugates of aminoguanidine and tryptamine: Nitric oxide synthase inhibition<br />

Douglas W Oliver, (South Africa), SF Malan, DK Wilkes, A de Vries<br />

Mon 443 Modulation of cognition and neuronal function in the age-accelerated mouse (SAMP8) by pterostilbene<br />

and resveratrol<br />

Merce Pallas, (Spain), J Chang, K Bryan, J Reeves, MA Smith, A Camins, A Rimando, B Shukitt-Hale,<br />

J Joseph, G Casadesus<br />

Mon 444 Prolyl oligopeptidase is not located in the long projection neurons of the rat brain<br />

Iida Peltonen, (Finland), TT Myöhänen, PT Männistö<br />

Mon 445 L-3-n-butylphthalide suppressed Lipopolysaccharide-induced inflammation through Nrf2 dependent<br />

pathway<br />

Ying Peng, (PR China), Y Hu, L Lu, S Xu, L Wang, X Wang<br />

Mon 446 Silvergold-cyankali methods for staned glial cells<br />

Bojana Petrovic, (Republic of Serbia), Z Zoric, D Drekic<br />

Mon 447 Spontaneous and amphetamine –induced locomotor activity in A30P -transgenic mice<br />

Marjo Piltonen, (Finland), S Patrikainen, PT Männistö<br />

Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 195

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!